Rigel Pharmaceuticals, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

FAIR VALUE (Tables)

FAIR VALUE (Tables)

12 Months Ended

Dec. 31, 2014

Schedule of financial assets measured at fair value on a recurring basis

Financial assets measured at fair value on a recurring basis are categorized in the tables below based upon the lowest level of significant input to the valuations (in thousands):

	Assets at Fair Value as of December 31, 2014
	Level 1		Level 2		Level 3		Total
Money market funds	$	10,027	$	—	$	—	$	10,027
U. S. treasury bills		—		2,010		—		2,010
Government-sponsored enterprise securities		—		45,786		—		45,786
Corporate bonds and commercial paper		—		85,161		—		85,161

Total	$	10,027	$	132,957	$	—	$	142,984

	Assets at Fair Value as of December 31, 2013
	Level 1		Level 2		Level 3		Total
Money market funds	$	9,059	$	—	$	—	$	9,059
U. S. treasury bills		—		2,085		—		2,085
Government-sponsored enterprise securities		—		67,178		—		67,178
Corporate bonds and commercial paper		—		133,458		—		133,458

Total	$	9,059	$	202,721	$	—	$	211,780